IgG response to the immunoreactive region of parvovirus B19 nonstructural protein by immunoblot assay with recombinant antigen

Journal of Infectious Diseases

Volumn 178, Issue 6, 1998, Pages 1826-1829

  Venturoli, Simona ^a   Gallinella, Giorgio ^a   Manaresi, Elisabetta ^a   Gentilomi, Giovanna ^a   Musiani, Monica ^a   Zerbini, Marialuisa ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PARVOVIRUS; PRIORITY JOURNAL; SEROLOGY; VIRUS INFECTION;

ANTIBODY FORMATION; ANTIGENS, VIRAL; ARTHRITIS; FEMALE; HEMATOLOGIC DISEASES; HUMANS; HYDROPS FETALIS; IMMUNOGLOBULIN G; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RECOMBINANT PROTEINS; REFERENCE VALUES; VIRAL NONSTRUCTURAL PROTEINS;

EID: 0031794771     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314500     Document Type: Article

References (15)

1. Astell CR, Weixing L, Brunstein J, Amand JS. The genome of B19 parvovirus. Monogr Virol 1996;20:16-41.
2. Ozawa K, Kurtzman G, Young NS. Replication of the B19 parvovirus in human bone marrow cell cultures. Science 1986;233:883-6.
3. Srivastava S, Bruno E, Bridell R, et al. Parvovirus B19-induced perturbation of megakaryocytopoiesis in vitro. Blood 1990;75:1997-2004.
4. Liu L, Green S, Shimada T, Young NS. A block in full-length transcript maturation in cells nonpermissive for B19 parvovirus. J Virol 1992;66:4686-92.
5. Brown KE. Human parvovirus B19 epidemiology and clinical manifestations. Monogr Virol 1997;207:42-60.
6. Foto F, Saag KG, Scharosh LL, Howard EJ, Naides SJ. Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence. J Infect Dis 1993;167:744-8.
7. Söderlurid M, von Essen R, Haapasaari J, Kiistala U, Kiviluoto O, Hedman K. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 1997;349:1063-5.
8. Cassinotti P, Burtonboy G, Fopp M, Siegl G. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol 1997;53:229-32.
9. Von Poblotzki A, Gigler A, Lang B, Wolf H, Modrow S. Antibodies to parvovirus B19 NS-1 protein in infected individuals. J Gen Virol 1995;76:519-27.
10. Von Poblotzki A, Hemauer A, Gigler A, et al. Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implication for pathogenesis. J Infect Dis 1995;172:1356-9.
11. Musiani M, Azzi A, Zerbini M, et al. Nested polymerase chain reaction assay for the detection of B19 parvovirus DNA in human immunodeficiency virus patients. J Med Virol 1993;40:157-60.
12. Blundell MC, Beard C, Astell CR. In vitro identification of a B19 parvovirus promoter. Virology 1987;157:534-8.
13. Shade RO, Blundell ML, Cotmore SF, Tattersal P, Astel CR. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol 1986;58:921-36.
14. Zerbini M, Musiani M, Gentilomi G, Venturoli S, Gallinella G, Morandi R. Comparative evaluation of virological and serological methods in prenatal diagnosis of parvovirus B19 fetal hydrops. J Clin Microbiol 1996;34:603-8.
15. Musiani M, Zerbini M, Gentilomi G, Plazzi M, Gallinella G, Venturoli S. Parvovirus B19 clearance from peripheral blood after acute infection. J Infect Dis 1995;172:1360-3.